683 related articles for article (PubMed ID: 29521057)
21. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome in women with and without interstitial cystitis/bladder pain syndrome.
Peng L; Di XP; He SX; Zeng X; Shen H; Zhu HL; Luo DY
Int Urogynecol J; 2021 May; 32(5):1299-1306. PubMed ID: 33215272
[TBL] [Abstract][Full Text] [Related]
23. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
24. Increased Transient Receptor Potential Melastatin 8 Expression in the Development of Bladder Pain in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Wu L; Zhang J; Zhou F; Zhang P
Urology; 2020 Dec; 146():301.e1-301.e6. PubMed ID: 33045289
[TBL] [Abstract][Full Text] [Related]
25. Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome.
Cho KJ; Lee KS; Choi JB; Koh JS; Kim JC
Investig Clin Urol; 2020 May; 61(3):304-309. PubMed ID: 32377607
[TBL] [Abstract][Full Text] [Related]
26. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
27. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
Kim SR; Moon YJ; Kim SK; Bai SW
Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
29. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
[TBL] [Abstract][Full Text] [Related]
30. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
Kochiashvili G; Kochiashvili D
Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
[TBL] [Abstract][Full Text] [Related]
31. Pelvic Floor Myofascial Pain Might Influence Treatment Outcome of Interstitial Cystitis/Bladder Pain Syndrome: A Prospective Study.
Yu WR; Chuang FC; Chang WC; Kuo HC
Pain Physician; 2022 Nov; 25(8):E1315-E1322. PubMed ID: 36375205
[TBL] [Abstract][Full Text] [Related]
32. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
[TBL] [Abstract][Full Text] [Related]
33. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
Chung SD; Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
[TBL] [Abstract][Full Text] [Related]
34. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
35. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
[TBL] [Abstract][Full Text] [Related]
36. A genome-scale DNA methylation study in women with interstitial cystitis/bladder pain syndrome.
Bradley MS; Burke EE; Grenier C; Amundsen CL; Murphy SK; Siddiqui NY
Neurourol Urodyn; 2018 Apr; 37(4):1485-1493. PubMed ID: 29363787
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
Niimi A; Igawa Y; Aizawa N; Honma T; Nomiya A; Akiyama Y; Kamei J; Fujimura T; Fukuhara H; Homma Y
Neurourol Urodyn; 2018 Mar; 37(3):1113-1119. PubMed ID: 29048741
[TBL] [Abstract][Full Text] [Related]
38. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
[TBL] [Abstract][Full Text] [Related]
39. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls.
Thu JHL; Vetter J; Lai HH
Urology; 2019 Aug; 130():59-64. PubMed ID: 31034917
[TBL] [Abstract][Full Text] [Related]
40. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis.
Homma Y; Nomiya A; Tagaya M; Oyama T; Takagaki K; Nishimatsu H; Igawa Y
J Urol; 2013 Nov; 190(5):1925-31. PubMed ID: 23727186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]